Ifosfamide is a type of chemotherapy drug. It works by stopping cancer cells from growing and dividing. It's used to treat certain types of cancer, like lymphoma and sarcoma. It's given as an injection, usually into a vein.
Every report comes from a Lived member, sent anonymously.
Have you tried Ifosfamide for Ewing Sarcoma?
Ifosfamide is a chemotherapy medicine given through a vein (intravenously) in a hospital or infusion center. In the United States it is sold under the brand name Ifex and as generic versions. Its FDA-approved use is for adults with germ cell testicular cancer that has needed two earlier chemotherapy treatments, where ifosfamide is given together with other cancer drugs as a third line of treatment. Cancer specialists also use ifosfamide outside that approval, most often for sarcomas (cancers that start in bone or in soft tissues such as muscle), and sometimes for certain bladder, lung, ovarian and cervical cancers. In a large trial of people with Ewing sarcoma, a rare bone cancer that mostly affects teenagers and young adults, that had come back or stopped responding to treatment, the typical (median) survival was 15.4 months with high-dose ifosfamide compared with 10.5 months with a different two-drug combination. Ifosfamide is usually one part of a multi-drug plan rather than a treatment on its own.
Ifosfamide belongs to a group of chemotherapy drugs called alkylating agents. It is inactive as given: enzymes in the liver convert it into a compound that attaches to DNA and links its strands together. A cell whose DNA is cross-linked cannot copy its genetic material properly and dies. Cancer cells divide often, so they are especially vulnerable, but fast-dividing healthy cells in the bone marrow, hair follicles and gut lining are affected too, which explains many of the side effects. The same conversion also produces by-products that cause much of ifosfamide's harm. One, called acrolein, passes into the urine and irritates the lining of the bladder. Another can injure the brain and kidneys. Much of the care that surrounds an ifosfamide infusion exists to limit these by-products.
Ifosfamide is given only by a cancer care team, as an infusion into a vein lasting at least 30 minutes. Treatment comes in cycles. A standard schedule is one infusion on each of five days in a row, repeated about every three weeks, once blood counts have recovered from the previous cycle. The oncologist sets the dose based on body size, the type of cancer, the other drugs in the regimen, kidney function and how earlier cycles went, and may delay or lower a dose when needed. Two measures accompany every course to protect the bladder. Mesna, a protective drug given alongside each dose, neutralizes the irritating by-product in the urine. Generous fluids, at least 2 liters a day by drinking or by IV, keep urine flowing so the bladder is not exposed for long. People are usually encouraged to drink well and pass urine often on treatment days. A urine test is checked before each dose, and treatment is held if it shows blood.
Hair loss affects about 9 in 10 people who receive ifosfamide, and nausea and vomiting affect about half. Tiredness, loss of appetite, mouth sores and diarrhea can also occur. The most important effect is a drop in blood counts. White blood cells are usually lowest in the second week after a cycle, when infections are more likely and can become serious quickly. Low platelets can cause bleeding, and low red cells add to fatigue. Fever, chills or other signs of infection, and unusual bleeding or bruising, black or bloody stools or vomiting blood, call for contacting the cancer care team right away, including after hours. Ifosfamide can also affect the brain, a reaction called encephalopathy. It can begin within hours to days of an infusion and shows up as confusion, unusual sleepiness, hallucinations, blurred vision, trouble speaking or poor balance. People around the patient often notice it first, and it should be reported to the care team immediately. A seizure, or being impossible to wake, needs emergency care: call 911. Blood in the urine, or urination that is painful, urgent or very frequent, can signal bleeding inflammation of the bladder (hemorrhagic cystitis) and should be reported promptly. So should passing much less urine than usual or new swelling of the face, hands or legs, which can point to kidney injury. New or worsening cough or shortness of breath, chest pain, or a racing or irregular heartbeat are less common but also need prompt attention, since ifosfamide can occasionally harm the lungs or heart.
Ifosfamide is not given to people whose urine flow is blocked, because urine has to carry the drug's irritating by-product out of the body, or to anyone who has had an allergic reaction to it. The care team also needs to know about kidney disease, heart disease, past radiation (especially to the bladder or chest), a current urinary tract infection and any earlier chemotherapy, since each raises the risk of particular harms. Busulfan, another chemotherapy drug, increases the risk of bladder bleeding, and cisplatin, a chemotherapy drug that can strain the kidneys, raises the risk of brain effects. The liver enzyme that activates ifosfamide is called CYP3A4. Medicines and herbs that speed up this enzyme, including the herbal supplement St. John's wort, can increase toxicity, while medicines that slow it may make ifosfamide less effective. Share a full list of prescriptions, over-the-counter products and supplements before treatment begins. Alcohol and medicines that act on the brain, such as sedatives, can add to the risk of confusion. Ifosfamide can seriously harm a developing baby, so pregnancy is ruled out before starting. Women who could become pregnant should use effective birth control during treatment and for 12 months after the last dose. Men with a partner who could become pregnant should use it during treatment and for 6 months after. Breastfeeding should stop during treatment and for one week after the last dose. Ifosfamide can also cause infertility in both men and women, sometimes permanently, so options for preserving fertility are worth discussing before the first cycle.
Each cycle involves several days of infusions followed by a recovery period, and the number of cycles depends on the cancer and the regimen. Blood counts, kidney function and urine are checked before each cycle, and a cycle may be postponed or the dose reduced if counts have not recovered or earlier side effects were severe. The week or two after each cycle, when blood counts are at their lowest, is the time to be most alert for fever. Ifosfamide can cause drowsiness, dizziness or blurred vision, so it is wise not to drive until it is clear how it affects you. Tell any surgeon or dentist about treatment, because it can slow wound healing. The care team judges whether the cancer is responding with scans or other tests during and after the course, and response varies with the type and stage of cancer. Some effects can appear or persist long after treatment ends. Kidney damage can develop months or even years later, so kidney checks may continue during follow-up. Ifosfamide also raises the risk of other cancers, including leukemia, which can appear several years after chemotherapy.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Ifosfamide, what you've noticed, or ask the community a question.